First image of the tested substance
First image of the tested substance
Second image of the tested substance
First image of the tested substance
Second image of the tested substance
Second image of the tested substance

Active ingredients and content

1cP-LSD

qualitative

Details of the substance tested

Thickness

1.5 mm

Length x width

3.0 mm

Diameter

Weight

14.1 mg

Colour

Colour

violet

Fracture groove

Yes

Relevant substance(s)

Risk assessment

This tablet does not contain LSA (ergin), but the hallucinogenic LSD derivative 1cP-LSD (1-cyclopropionyl-LSD). 1cP-LSD is most likely a prodrug of LSD; it converts to LSD in the body. 1cP-LSD also has a very similar or identical effect to LSD according to users. 1cP-LSD is reported to produce fewer visual effects than LSD. However, there are only a few field reports and hardly any scientific papers on this substance.

Like LSD, 1cP-LSD can also lead to highly intense psychedelic experiences, which can be disturbing and frightening. The effect of 1cP-LSD, like LSD, is strongly dependent on one's own state of mind (set) and the environment (setting), in addition to the dose.

There is hardly any information available on risks, side effects and long-term consequences. Therefore, consumption is not recommended!

Alert level

Safer Use

Analysis

Have your substances tested in a drug check.

Testing

If you do not have the possibility to have substances analyzed, first test a maximum of one third of the pill, since very many high-dose pills are in circulation.

Wait and see

Wait 2 hours after taking the medication, as there are always pills with unexpected active ingredients in circulation, which can have a later onset of action.

Drinking

Remember: drink non-alcoholic and isotonic drinks (3 dl / hour) and take breaks in the fresh air from time to time to prevent overheating / dehydration.

Similar warnings

There are no current warnings for this substance

Things to know